Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab?
PaperCitations, authors & open-access status
Targeting CD20 in Primary Membranous Nephropathy Serologically and Histologically Negative for PLA2R: Is Obinutuzumab Superior to Rituximab? is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2025 year and gold oa status.
2
Citations
2025
Year
gold
OA Status